EVALUATION OF 4F-PCC IN OBESE VERSUS NON-OBESE PATIENTS FOR FACTOR XA INHIBITOR REVERSAL

被引：0
|
作者：
Ciborowski, Megan
Nakajima, Steven
Sparks, Eric [1 ]
McKinney, James, III [1 ]
机构：
[1] New Hanover Reg Med Ctr, Wilmington, NC USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1791
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FIXED-DOSE 4F-PCC FOR REVERSAL OF FACTOR XA INHIBITOR FOR INTRACRANIAL HEMORRHAGE
    Anderson, Whitney
    Middleton, Grant
    Svelund, Elizabeth
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [2] IMPACT OF FIXED-DOSE 4F-PCC VERSUS WEIGHT-BASED 4F-PCC FOR FACTOR XA INHIBITOR MAJOR BLEEDING
    Ioppolo, Lacey
    Rottman, Kathleen
    Cannon, Chad
    Hayes, Sarah
    Allen, Bryan
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 159 - 159
  • [3] SAFETY OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES (4F-PCC) FOR THE REVERSAL OF FACTOR XA INHIBITORS
    Tao, Jing
    Bukanova, Elena
    Akhtar, Shamsuddin
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 98 - 100
  • [4] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [5] EVALUATION OF FIXED-DOSE VERSUS WEIGHT-BASED DOSING OF 4F-PCC FOR ORAL FACTOR XA INHIBITOR BLEEDING
    Ellenburg, Jessica
    Beck, Julie
    Casey, Jessica
    Kallenberger, Michael
    John, Jeremy
    Musselman, Megan
    CRITICAL CARE MEDICINE, 2024, 52
  • [6] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [7] Comparative hemostatic efficacy of 4F-PCC in patients with intracranial hemorrhage on factor Xa inhibitors versus warfarin
    Heath, Megan
    Hall, Brad
    De Leon, Jason
    Gillespie, Rita
    Hasara, Shannon
    Henricks, Bret
    Lakshmi, Magge
    Watson, Davin
    Wilson, Kayla
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 57 : 149 - 152
  • [8] EVALUATION OF 4F-PCC IN THE MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH ORAL FACTOR XA INHIBITORS
    Deloney, Lindsay
    Tatum, Cassandra
    Weant, Kyle
    Eriksson, Evert
    Smith, Melanie
    CRITICAL CARE MEDICINE, 2019, 47
  • [9] EVALUATION OF UNFRACTIONATED HEPARIN DOSING IN NON-OBESE VERSUS OBESE PATIENTS FOR VTE
    Flanagan, Trenton
    Sharma, Monica
    Wang, Xuan
    Cao, Uyen-Thi
    Kataria, Vivek
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [10] Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients
    Manuel Isherwood
    Michelle L. Murphy
    Angela L. Bingham
    Laura A. Siemianowski
    Krystal Hunter
    James M. Hollands
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 476 - 483
12345